Annual report for Fredun Pharmaceuticals Ltd. for FY-2019
12-06-2019
Fredun Pharmaceuticals Ltd - 539730 - Corporate Action-Board approves Dividend
The Board in its meeting had considered and approved the Dividend of Rs. 0.60/- per Rs.10/- Equity Share of the Company.11-06-2019
Fredun Pharmaceuticals Ltd - 539730 - Financial Results For The Year Ended March 31, 2019
In compliance to Regulation 33 ofSEBI Listing Regulations, 2015; we wish to inform you that the Board of Directors of Fredun Pharmaceuticals Limited (hereinafter referred to as 'the Company'), at their Meeting held on Monday, June 10, 2019; had considered and approved the Financial Results for the year ended March 31, 2019.11-06-2019
Fredun Pharmaceuticals Ltd - 539730 - Announcement under Regulation 30 (LODR)-Newspaper Publication
We enclose herewith the copies of the Notice of the ensuing Board Meeting of the Company scheduled to be held on Monday, June 10, 2019; published in Business Standard & Mumbai Lakshadeep newspapers on June 4, 2019.04-06-2019
Fredun Pharmaceuticals Ltd - 539730 - Board Meeting Intimation for Approval Audited Financial Results
Fredun Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/06/2019 ,inter alia, to consider and approve We wish to inform you that the 172nd Meeting of the Board of Directors of the Company is scheduled to be held on Monday, June 10, 2019 at 3:00 P.M. at the Registered Office of the Company.03-06-2019
Fredun Pharmaceuticals Ltd - 539730 - Cancellation of Board Meeting
The Board Meeting to be held on 30/05/2019 Stands Cancelled.30-05-2019
Fredun Pharmaceuticals Ltd - 539730 - Declaration With Regard To Large Corporate
With reference to the captioned subject, we would like to inform that the Company is not a Large Corporate, as per the criteria provided in clause 2.2 of said SEBI Circular for the year ended March 31, 2019. Accordingly, the initial disclosure in Annexure A to the said Circular is not applicable to the Company.29-05-2019
Fredun Pharmaceuticals Ltd - 539730 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
The Company wish to bring to your kind notice that the shareholder has reported our Share Transfer Agency - Purva Sharegistry (India) Pvt. Ltd. about his / her loss of Share Certificate(s) and have requested for issuance of Duplicate Share Certificate(s); in lieu of their Original 1,000 Share Certificates been lost.25-05-2019
Fredun Pharmaceuticals Ltd - 539730 - Announcement under Regulation 30 (LODR)-Newspaper Publication
We enclose herewith the copies of the Notice of the ensuing Board Meeting of the Company scheduled to be held on Thursday, May 30, 2019; published in Business Standard & Mumbai Lakshadeep newspaper on May 21, 201921-05-2019
Fredun Pharmaceuticals Ltd - 539730 - Board to consider Dividend
Fredun Pharmaceuticals Ltd has informed BSE that the Meeting of the Board of Directors of the Company is scheduled to be held on May 30, 2019, inter alia, for the following matters:1. To discuss, consider and approve the Audited Financial Results of the Company for the Quarter and Year endedMarch 31, 2019;2. To recommend Dividend if any, for the Financial Year ended March 2019 - subject to the approval of the Shareholders at the 32nd Annual General Meeting of the Company.Further, in continuation of Company's intimation dated April 04, 2019 and pursuant to Company's "Code of Conduct forPrevention of insider Trading" the trading window for dealing in the securities of the Company is closed from April 04, 2019 to June 01, 2019 (both days inclusive).The same has been circulated to the Directors, Key Managerial Personnel, Employees of the Company.20-05-2019